Annie Lee Pei Wen

Title: The Innovative Contributions of Annie Lee Pei Wen

Introduction

Annie Lee Pei Wen is a notable inventor based in Kuala Lumpur, Malaysia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. Her work focuses on selective COX-2 inhibition, which has important implications for pain management and inflammation treatment.

Latest Patents

Annie Lee holds a patent for her invention titled "Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-N-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agents." This patent includes novel compounds that are identified as COX-2 inhibitors, which are useful in treating inflammation and pain. The patent also details a method for synthesizing these compounds, a pharmaceutical composition comprising them, and a method of using the compounds.

Career Highlights

Annie Lee is affiliated with King Fahd University of Petroleum and Minerals, where she continues her research and development in the pharmaceutical field. Her innovative work has garnered attention for its potential to improve therapeutic options for patients suffering from inflammatory conditions.

Collaborations

Annie has collaborated with esteemed colleagues, including Katharigatta N Venugopala and Pran Kishore Deb. These collaborations have further enhanced her research and contributed to the advancement of her patented technologies.

Conclusion

Annie Lee Pei Wen's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor in anti-inflammatory research. Her work not only showcases her expertise but also promises to impact the medical community positively.